NCT06315231: Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients |
|
|
| Recruiting | 2 | 200 | RoW | Edaravone dexborneol sublingual tablet, Placebo | Simcere Pharmaceutical Co., Ltd | Post-stroke Cognitive Impairment | 12/26 | 12/26 | | |
NCT06777485: China Liver Cancer Clinical Registry Cohort Database |
|
|
| Recruiting | N/A | 10000 | RoW | Procedure/Surgery treatment, Anti-Tumor Drugs | Anhui Provincial Hospital | Liver Cancer | 01/35 | 01/35 | | |